aTyr Pharma, Inc.ATYRNASDAQ
Loading
Stockholders Equity Over TimeStable
Percentile Rank62
3Y CAGR-1.9%
5Y CAGR+16.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-1.9%/yr
vs +20.7%/yr prior
5Y CAGR
+16.3%/yr
Recent deceleration
Acceleration
-22.6pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $67.48M | -3.6% |
| 2024 | $70.02M | -22.8% |
| 2023 | $90.66M | +26.9% |
| 2022 | $71.46M | -34.6% |
| 2021 | $109.30M | +245.3% |
| 2020 | $31.65M | +49.4% |
| 2019 | $21.19M | -37.0% |
| 2018 | $33.65M | -47.6% |
| 2017 | $64.25M | +2.3% |
| 2016 | $62.80M | - |